Hikma Pharmaceuticals Plc - Company Profile
Powered by
All the data and insights you need on Hikma Pharmaceuticals Plc in one report.
- Save hours of research time and resources with
our up-to-date Hikma Pharmaceuticals Plc Strategy Report
- Understand Hikma Pharmaceuticals Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Hikma Pharmaceuticals Plc Clinical Trials
Determine Hikma Pharmaceuticals Plc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Hikma Pharmaceuticals Plc Clinical Trials data
Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
---|---|---|---|---|---|---|---|
Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
Efficacy and Safety of Generic Imatinib (Carcemia) Compared to Glivec in Real-life Management of Chronic Phase of Chronic Myeloid Leukemia (CARCML) | GDCT0450760 | imatinib mesylate | Oncology | Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) | Phase IV | Planned | Hikma Pharmaceuticals LLC |
Bioequivalence Study of Vonoprazan From Topoprazan 20 mg Tablets (Hikma Pharma, Egypt) Versus Takecab 20 mg Tablets (Takeda Pharmaceutical Co. Ltd., Japan) | GDCT0440479 | vonoprazan | Gastrointestinal | Corrosive Esophagitis (Erosive Esophagitis); Duodenal Ulcer; Gastric Ulcers; Gastritis; Reflux Esophagitis (Gastroesophageal Reflux Disease) | Phase I | Completed | Genuine Research Center |
Bioequivalence Study of Empagliflozin & Metformin HCL From Empagliform 12.5/1000 mg F.C.T (Hikma Pharma, Egypt) and Synjardy 12.5/1000 mg F.C.T (Boehringer Ingelheim International GmbH, Germany) | GDCT0440033 | Empagliform | Metabolic Disorders | Type 2 Diabetes | Phase I | Completed | Genuine Research Center |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer